Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Total Current Liabilities (2022 - 2025)

Moolec Science (MLECW) posted Total Current Liabilities of $61.9 million for Q4 2025, down 73.78% sequentially from $236.1 million in Q2 2025, and up 858.22% YoY from $6.5 million in Q4 2024.

Moolec Science (MLECW) Total Current Liabilities (2022 - 2025) Analysis & Trends

Moolec Science has reported Total Current Liabilities for 4 years, with the latest figure at $61.9 million in Q4 2025.

  • Quarterly Total Current Liabilities rose 858.22% year-over-year to $61.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $61.9 million (up 858.22% YoY) and the FY2025 annual result came in at $236.1 million, down 44.77% from the prior year.
  • Total Current Liabilities fell to $61.9 million in Q4 2025 per MLECW's latest filing, from $236.1 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $427.4 million in Q2 2024 and troughed at $2.9 million in Q1 2023.
  • A 4-year average of $68.0 million and a median of $9.8 million in 2022 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 1312.97% in 2024, then plunged 44.77% in 2025.
  • Over 4 years, Total Current Liabilities stood at $11.3 million in 2022, then declined by 26.57% to $8.3 million in 2023, then declined by 22.02% to $6.5 million in 2024, then jumped by 858.22% to $61.9 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $61.9 million, $236.1 million, and $6.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.51 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 2.49 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 438.74 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 630.93 Mn
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 61.88 Mn
Jun 30, 2025 236.05 Mn
Dec 31, 2024 6.46 Mn
Sep 30, 2024 7.36 Mn
Jun 30, 2024 427.40 Mn
Mar 31, 2024 7.82 Mn
Dec 31, 2023 8.28 Mn
Sep 30, 2023 12.51 Mn
Jun 30, 2023 30.25 Mn
Mar 31, 2023 2.92 Mn
Dec 31, 2022 11.28 Mn
Jun 30, 2022 4.09 Mn